Navigation Links
Gen-Probe and DiagnoCure Amend Collaboration Agreement Surrounding PCA3-Based Prostate Cancer Tests
Date:4/29/2009

noCure Oncology Laboratories, a subsidiary of DiagnoCure Inc., launched in 2008 the Previstage(TM) GCC Colorectal Cancer Staging Test, the first GCC-based molecular test for the management of colorectal cancer. A major study published in the February 18, 2009, edition of the JAMA ("Journal of the American Medical Association") demonstrated that GCC is the strongest independent predictor of colorectal cancer recurrence in patients considered low risk by current assessment methods. The Company also has a strategic alliance with Gen-Probe (Nasdaq: GPRO) for the development and commercialization of a second-generation prostate cancer test using PCA3, DiagnoCure's proprietary molecular marker. This test is also available through laboratories in the U.S. using PCA3 analyte specific reagents (ASR) manufactured by Gen-Probe, in Europe as the CE-marked PROGENSA(TM) PCA3 in vitro assay, and in Canada. In addition to its own research, the Company intends to acquire or in-license additional promising cancer biomarkers from both academic and commercial institutions. For more information, visit www.diagnocure.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about Gen-Probe's or DiagnoCure's expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as believe, will, expect, anticipate, estimate, intend, plan and would. For example, statements concerning new products, potential regulatory approvals and customer adoption are all forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
2. Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
3. Gen-Probe Announces Webcast of Third Quarter 2007 Earnings Conference Call
4. New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation
5. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
6. Study Protocols Will be Amended in Two Small Early-Phase Prasugrel Studies
7. Prometheus and Rosetta Genomics Announce License and Collaboration Agreement
8. Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
9. Endo Pharmaceuticals Announces Research Collaborations to Develop Novel Pain Treatments and Discover Potential Cancer Treatments
10. Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration
11. Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015  CTI BioPharma Corp. (NASDAQ and MTA: CTIC) ... March 31, 2015. "After reporting ... trial of pacritinib during the quarter, we have subsequently ... who are excited by the potential opportunity for pacritinib ... treatment of patients with myelofibrosis, specifically in the portion ...
(Date:5/6/2015)... May 6, 2015  Mirati Therapeutics, Inc. ("Mirati") (NASDAQ: ... first quarter ended March 31, 2015 and provided an ... "We continue to make progress across our targeted oncology ... Ph.D., president and CEO, Mirati. "We look forward to ... Society of Clinical Oncology meeting at the end of ...
(Date:5/6/2015)... -- Delcath Systems, Inc. (NASDAQ: DCTH ), a ... with an emphasis on the treatment of primary and ... months ended March 31, 2015.  Highlights ... , Achieved quarterly product revenue of $0.44 million, an ... quarter of 2014; , Activated a prospective patient ...
Breaking Medicine Technology:CTI BioPharma Reports First Quarter 2015 Financial Results 2CTI BioPharma Reports First Quarter 2015 Financial Results 3CTI BioPharma Reports First Quarter 2015 Financial Results 4CTI BioPharma Reports First Quarter 2015 Financial Results 5CTI BioPharma Reports First Quarter 2015 Financial Results 6CTI BioPharma Reports First Quarter 2015 Financial Results 7CTI BioPharma Reports First Quarter 2015 Financial Results 8CTI BioPharma Reports First Quarter 2015 Financial Results 9Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 2Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 3Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 4Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update 5Delcath Reports 2015 First Quarter Financial Results 2Delcath Reports 2015 First Quarter Financial Results 3Delcath Reports 2015 First Quarter Financial Results 4Delcath Reports 2015 First Quarter Financial Results 5Delcath Reports 2015 First Quarter Financial Results 6Delcath Reports 2015 First Quarter Financial Results 7Delcath Reports 2015 First Quarter Financial Results 8
... Cardica, Inc. (Nasdaq: CRDC ) today ... marketing. In this role, Mr. Littel will be responsible ... Cardica,s existing cardiac surgery devices and its planned MicroCutter™ ... surgery. "Chris brings experience as a successful ...
... -- ShangPharma Corporation (NYSE: SHP ) ... and biotechnology research and development outsourcing company, today ... subsidiary, Shanghai ChemPartner Co. Ltd. ("ChemPartner"), acquired the ... River") Shanghai research facility. As ...
Cached Medicine Technology:Cardica Appoints Christopher Littel VP, Sales and Marketing 2Cardica Appoints Christopher Littel VP, Sales and Marketing 3ShangPharma Purchases Shanghai In-vivo Drug Research Facility from Charles River 2
(Date:5/6/2015)... Texas (PRWEB) May 06, 2015 ... of the HIMSS EMR Adoption Model, the hospital ... improve patient engagement and automate processes. The leadership ... from paper-driven to electronic workflows, patient registration still ... copies of consents. With HIMSS Stage 7 attestation ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Corporate ... behalf of MEBC, an Alliance Award for excellence ... during FOCUS 2015, JDA’s annual user conference which ... retail and wholesale distribution sectors. This award recognizes ... are receiving services that advance their supply chain ...
(Date:5/6/2015)... 06, 2015 The Beryl Institute announces ... of Patient Experience Journal (PXJ), an international, open access, ... understanding and improving patient experience. The second volume of ... conversation globally, helps align the voices engaged and provides ... Published in association with The Beryl Institute, Volume 2, ...
(Date:5/6/2015)... Marketing Maven announces a ... sanitation and hygiene nonprofit by GuideStar’s Philanthropedia. , “WaterAid ... and it brings our agency great joy to work ... “The ongoing relationship between WaterAid and Marketing ... learn about and support the nonprofit as they aim ...
(Date:5/6/2015)... 06, 2015 Wolters Kluwer , ... and students, announced today that in a survey of ... use of the clinical decision support resource improves the ... of 2014, UpToDate users in more than 170 countries ... month, on average. In Germany alone, 95% of all ...
Breaking Medicine News(10 mins):Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3
... 500 Executive Driving Global Breast Cancer Leader,s Promise ... End Breast Cancer Forever, ATLANTA, Jan. 12 Hala ... the global leader in the fight to end breast,cancer forever, ... annual Trumpet Awards event in Atlanta with a ,High Heels ...
... Diseases than Ever ... ... childhood influenza and adolescent meningococcal,vaccinations are included in the 2008 Childhood ... Control and,Prevention (CDC), the American Academy of Pediatrics (AAP), and the,American ...
... NEW YORK, Jan. 11 The Substance Abuse ... from the National Survey on Drug Use and ... S. aged 12 to 25 have abused non-prescription,over-the- ... high at least once,in their lifetime. This announcement ...
... health care reform is too important, the stakes for, Californians ... ... changes., SACRAMENTO, Calif., Jan. 11 As the ... hammered out by Governor Arnold Schwarzenegger and Assembly,Speaker Fabian Nunez, the state,s ...
... genetic, biological causes could lead more to feel comfortable ... When people understand the genetics and biology of anorexia ... the eating disorder for their illness, says a University ... , "This is a potentially important finding because it ...
... diet and lifestyle are at root of reduced risk, , , FRIDAY, ... in your blood may reduce your risk of stroke, new research ... C in their blood had a 42 percent lower risk of ... which is in the January issue of The ...
Cached Medicine News:Health News:Susan G. Komen for the Cure's CEO Hala Moddelmog Earns 'High Heels in High Places' Recognition at 2008 Trumpet Awards 2Health News:Susan G. Komen for the Cure's CEO Hala Moddelmog Earns 'High Heels in High Places' Recognition at 2008 Trumpet Awards 3Health News:Health Groups Release 2008 Immunization Schedules 2Health News:Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on New SAMHSA Study On Cough Medicine Abuse 2Health News:Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on New SAMHSA Study On Cough Medicine Abuse 3Health News:Statement of Steve Pasierb, President and CEO, Partnership for a Drug-Free America on New SAMHSA Study On Cough Medicine Abuse 4Health News:Insurance Agents Call for State Senate to Improve California's Health Care Reform Compromise 2Health News:Science Could Erase Stigma of Anorexia 2Health News:Vitamin C May Play Role in Stroke Prevention 2Health News:Vitamin C May Play Role in Stroke Prevention 3
Microseal 'F' foil, seals plates for cold storage (or cycling >25l), disposable, pkg of 100...
Pkg qty: box of 2 bags pack of 25 (Pack = Zippered Bag)...
Transparent film for easy visual monitoring of samples...
... Biosystems has developed a comprehensive set ... using sequence detection systems (SDS) reagents ... and easy to follow. Many traditional ... and the thermal cycling protocol itself, ...
Medicine Products: